These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 27068972
1. Using the fragment molecular orbital method to investigate agonist-orexin-2 receptor interactions. Heifetz A, Aldeghi M, Chudyk EI, Fedorov DG, Bodkin MJ, Biggin PC. Biochem Soc Trans; 2016 Apr 15; 44(2):574-81. PubMed ID: 27068972 [Abstract] [Full Text] [Related]
5. Characterizing Rhodopsin-Arrestin Interactions with the Fragment Molecular Orbital (FMO) Method. Heifetz A, Townsend-Nicholson A. Methods Mol Biol; 2020 Apr 15; 2114():177-186. PubMed ID: 32016894 [Abstract] [Full Text] [Related]
6. The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR-Ligand Interactions. Heifetz A, Chudyk EI, Gleave L, Aldeghi M, Cherezov V, Fedorov DG, Biggin PC, Bodkin MJ. J Chem Inf Model; 2016 Jan 25; 56(1):159-72. PubMed ID: 26642258 [Abstract] [Full Text] [Related]
8. Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery. Heifetz A, Southey M, Morao I, Townsend-Nicholson A, Bodkin MJ. Methods Mol Biol; 2018 Jan 25; 1705():375-394. PubMed ID: 29188574 [Abstract] [Full Text] [Related]
9. Structure-based drug design for G protein-coupled receptors. Congreve M, Dias JM, Marshall FH. Prog Med Chem; 2014 Jan 25; 53():1-63. PubMed ID: 24418607 [Abstract] [Full Text] [Related]
10. Fighting obesity with a sugar-based library: discovery of novel MCH-1R antagonists by a new computational-VAST approach for exploration of GPCR binding sites. Heifetz A, Barker O, Verquin G, Wimmer N, Meutermans W, Pal S, Law RJ, Whittaker M. J Chem Inf Model; 2013 May 24; 53(5):1084-99. PubMed ID: 23590178 [Abstract] [Full Text] [Related]
11. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists. Hagiwara Y, Ohno K, Kamohara M, Takasaki J, Watanabe T, Fukunishi Y, Nakamura H, Orita M. Expert Opin Drug Discov; 2013 Aug 24; 8(8):951-64. PubMed ID: 23682717 [Abstract] [Full Text] [Related]
12. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors. Bhunia SS, Saxena AK. Curr Top Med Chem; 2021 Aug 24; 21(4):269-294. PubMed ID: 32901584 [Abstract] [Full Text] [Related]
13. GPCR crystal structures: Medicinal chemistry in the pocket. Shonberg J, Kling RC, Gmeiner P, Löber S. Bioorg Med Chem; 2015 Jul 15; 23(14):3880-906. PubMed ID: 25638496 [Abstract] [Full Text] [Related]
14. X-ray structure breakthroughs in the GPCR transmembrane region. Topiol S, Sabio M. Biochem Pharmacol; 2009 Jul 01; 78(1):11-20. PubMed ID: 19447219 [Abstract] [Full Text] [Related]
15. Characterizing Interhelical Interactions of G-Protein Coupled Receptors with the Fragment Molecular Orbital Method. Heifetz A, Morao I, Babu MM, James T, Southey MWY, Fedorov DG, Aldeghi M, Bodkin MJ, Townsend-Nicholson A. J Chem Theory Comput; 2020 Apr 14; 16(4):2814-2824. PubMed ID: 32096994 [Abstract] [Full Text] [Related]
16. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study. Kooistra AJ, Leurs R, de Esch IJ, de Graaf C. J Chem Inf Model; 2015 May 26; 55(5):1045-61. PubMed ID: 25848966 [Abstract] [Full Text] [Related]
20. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations. Lee Y, Basith S, Choi S. J Med Chem; 2018 Jan 11; 61(1):1-46. PubMed ID: 28657745 [Abstract] [Full Text] [Related] Page: [Next] [New Search]